United States · FDA National Drug Code directory
SUPPRELIN LA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67979-002_917e915f-4793-48bf-84c3-50272421616f
- Product NDC
- 67979-002
- Form
- IMPLANT
- Composition / generic term
- histrelin acetate
- Labeler
- Endo USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070531
- Source listing expiry
- 20261231
Source-listed ingredients
- HISTRELIN ACETATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (67979-002-01) / 1 IMPLANT in 1 VIAL, GLASS · 67979-002-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →